IL40457A - Esters and salts of vincaminic and apovincaminic acid their preparation and pharmaceutical compositions containing them - Google Patents
Esters and salts of vincaminic and apovincaminic acid their preparation and pharmaceutical compositions containing themInfo
- Publication number
- IL40457A IL40457A IL40457A IL4045772A IL40457A IL 40457 A IL40457 A IL 40457A IL 40457 A IL40457 A IL 40457A IL 4045772 A IL4045772 A IL 4045772A IL 40457 A IL40457 A IL 40457A
- Authority
- IL
- Israel
- Prior art keywords
- acid
- group
- salts
- vincaminic
- general formula
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract 13
- UXMCFEBDJVHVNH-HOJAQTOUSA-N ac1l52id Chemical class C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(O)=O)N5C2=C1 UXMCFEBDJVHVNH-HOJAQTOUSA-N 0.000 title claims abstract 5
- 238000002360 preparation method Methods 0.000 title claims abstract 3
- ZFCQLDAGNBFMJQ-QUCCMNQESA-N apovincaminic acid Chemical class C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C=C(C(O)=O)N5C2=C1 ZFCQLDAGNBFMJQ-QUCCMNQESA-N 0.000 title claims 4
- 150000002148 esters Chemical class 0.000 title claims 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 238000000034 method Methods 0.000 claims abstract 10
- -1 alkaloid esters Chemical class 0.000 claims abstract 9
- 150000001875 compounds Chemical class 0.000 claims abstract 5
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims abstract 5
- 239000002253 acid Substances 0.000 claims abstract 4
- 125000000217 alkyl group Chemical group 0.000 claims abstract 4
- 150000001350 alkyl halides Chemical class 0.000 claims abstract 3
- 229910052736 halogen Inorganic materials 0.000 claims abstract 3
- 150000002367 halogens Chemical class 0.000 claims abstract 3
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract 3
- 239000011707 mineral Substances 0.000 claims abstract 3
- 150000007522 mineralic acids Chemical class 0.000 claims abstract 3
- 150000007524 organic acids Chemical class 0.000 claims abstract 3
- 229930013930 alkaloid Natural products 0.000 claims abstract 2
- 239000002904 solvent Substances 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 5
- 238000009835 boiling Methods 0.000 claims 4
- RXPRRQLKFXBCSJ-GIVPXCGWSA-N vincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@](O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-GIVPXCGWSA-N 0.000 claims 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 claims 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 3
- 125000004432 carbon atom Chemical group C* 0.000 claims 3
- 125000005843 halogen group Chemical group 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 239000000825 pharmaceutical preparation Substances 0.000 claims 3
- 229940127557 pharmaceutical product Drugs 0.000 claims 3
- OZDNDGXASTWERN-CTNGQTDRSA-N Apovincamine Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C=C(C(=O)OC)N5C2=C1 OZDNDGXASTWERN-CTNGQTDRSA-N 0.000 claims 2
- 239000013543 active substance Substances 0.000 claims 2
- 125000005092 alkenyloxycarbonyl group Chemical group 0.000 claims 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 2
- 229950006936 apovincamine Drugs 0.000 claims 2
- OZDNDGXASTWERN-UHFFFAOYSA-N apovincamine Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)C=C(C(=O)OC)N5C2=C1 OZDNDGXASTWERN-UHFFFAOYSA-N 0.000 claims 2
- 239000003153 chemical reaction reagent Substances 0.000 claims 2
- RXPRRQLKFXBCSJ-UHFFFAOYSA-N dl-Vincamin Natural products C1=CC=C2C(CCN3CCC4)=C5C3C4(CC)CC(O)(C(=O)OC)N5C2=C1 RXPRRQLKFXBCSJ-UHFFFAOYSA-N 0.000 claims 2
- 239000011541 reaction mixture Substances 0.000 claims 2
- 229960002726 vincamine Drugs 0.000 claims 2
- DDNCQMVWWZOMLN-RBBKRZOGSA-N (-)-ethyl apovincaminate Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@H]3[C@@]4(CC)C=C(C(=O)OCC)N5C2=C1 DDNCQMVWWZOMLN-RBBKRZOGSA-N 0.000 claims 1
- DNXIKVLOVZVMQF-UHFFFAOYSA-N (3beta,16beta,17alpha,18beta,20alpha)-17-hydroxy-11-methoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-yohimban-16-carboxylic acid, methyl ester Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(C(=O)OC)C(O)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 DNXIKVLOVZVMQF-UHFFFAOYSA-N 0.000 claims 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 1
- LCQMZZCPPSWADO-UHFFFAOYSA-N Reserpilin Natural products COC(=O)C1COCC2CN3CCc4c([nH]c5cc(OC)c(OC)cc45)C3CC12 LCQMZZCPPSWADO-UHFFFAOYSA-N 0.000 claims 1
- QEVHRUUCFGRFIF-SFWBKIHZSA-N Reserpine Natural products O=C(OC)[C@@H]1[C@H](OC)[C@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)C[C@H]2[C@@H]1C[C@H]1N(C2)CCc2c3c([nH]c12)cc(OC)cc3 QEVHRUUCFGRFIF-SFWBKIHZSA-N 0.000 claims 1
- 125000001931 aliphatic group Chemical group 0.000 claims 1
- 229910052783 alkali metal Inorganic materials 0.000 claims 1
- 150000001340 alkali metals Chemical class 0.000 claims 1
- 125000003342 alkenyl group Chemical group 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 239000002585 base Substances 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 239000003054 catalyst Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 125000004494 ethyl ester group Chemical group 0.000 claims 1
- XRMLLVHAALNSGZ-HJNYFJLDSA-N ethylvincaminate Chemical compound C1=CC=C2C(CCN3CCC4)=C5[C@@H]3[C@]4(CC)C[C@@](C(=O)OCC)(O)N5C2=C1 XRMLLVHAALNSGZ-HJNYFJLDSA-N 0.000 claims 1
- 150000004820 halides Chemical class 0.000 claims 1
- 235000005985 organic acids Nutrition 0.000 claims 1
- 125000003884 phenylalkyl group Chemical group 0.000 claims 1
- BJOIZNZVOZKDIG-MDEJGZGSSA-N reserpine Chemical compound O([C@H]1[C@@H]([C@H]([C@H]2C[C@@H]3C4=C([C]5C=CC(OC)=CC5=N4)CCN3C[C@H]2C1)C(=O)OC)OC)C(=O)C1=CC(OC)=C(OC)C(OC)=C1 BJOIZNZVOZKDIG-MDEJGZGSSA-N 0.000 claims 1
- 229960003147 reserpine Drugs 0.000 claims 1
- MDMGHDFNKNZPAU-UHFFFAOYSA-N roserpine Natural products C1C2CN3CCC(C4=CC=C(OC)C=C4N4)=C4C3CC2C(OC(C)=O)C(OC)C1OC(=O)C1=CC(OC)=C(OC)C(OC)=C1 MDMGHDFNKNZPAU-UHFFFAOYSA-N 0.000 claims 1
- DCKVNWZUADLDEH-UHFFFAOYSA-N sec-butyl acetate Chemical compound CCC(C)OC(C)=O DCKVNWZUADLDEH-UHFFFAOYSA-N 0.000 claims 1
- 229910052708 sodium Inorganic materials 0.000 claims 1
- 239000011734 sodium Substances 0.000 claims 1
- 239000011877 solvent mixture Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D461/00—Heterocyclic compounds containing indolo [3,2,1-d,e] pyrido [3,2,1,j] [1,5]-naphthyridine ring systems, e.g. vincamine
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A process for the preparation of pharmaceutically active eburnamine-type alkaloid esters of the general formula (I) of the accompanying drawings, wherein X"-".y represents a =C=CH or CCH^group, and OH R repre eivsa CV6 alko^ycarbonyt orC-s alkenylo^ycarbo-ny! group optionally mbsiiiuted wi h ahydro>.y group or w;tha halogen a om or salt- orrjua ernary dertva";ves ihereof in which a salt of apovincaniinic acid or of vincaminic acid is reacted with a C,-o alkyl halidc and C^o alkenyt hafide, bodi substituted by halogen or hydroxy group, and, if desired, the thus-obtained compounds of the general formula (1) are converted into their acid addition salts or quaternary salts by reacting them wjt(i a mineral or organic acid or with an alkyl halide, respectively. [IN138719]
Claims (2)
1. -22- 40457/3 CLAIMS : l) Eburnamine-type alkaloid esters of the general formula (I) R represents an unsubntitutod olkoxycarbonyl group containing 2 to 6 cnrbon atoms in the n.lkyl rnoy ty; a C2-6 alkoxycarbonyl group substituted with a hydroxy group or with a halogen atom, an alkenyloxycarbonyl group or a phenylalkoxycarbony1 group, or their salts or quaternary derivatives.
2. ) Vincaminic acid ethyl ester* 5) Vincaminic acid allyl ester. ) Vincaminio acid hydroxyethyl ester. 5) Vincaminic acid chloroethyl ester. 6) Vincaminic aoid benzyl ester. 7) Apovincaminic acid ethyl eeter in any of ite optically aotive isomers. 8) (-) -Apovincaminic acid ethyl ester. 9) Apovinoaminic aoid ethyl ester methoiodide. 10) Apovinoaminio aoid butyl ester* 40457/4 2 to 6 carbon atoms in the alkyl moiety; a C2_g alkoxycarbonyl group substituted with a hydroxy group or with a halogen atom, an alkenyloxycarbonyl group or a phenylalkoxycarbonyl group, or salts or quaternary derivatives thereof, in which a) a salt of apovincaminic acid or of vincaminic acid is reacted with a C2_g alkyl halide, C2_g alkyl halide substituted with a halogen or a hydroxy group, alkenyl halide, phenylalkyl halide or with the corresponding sulfates, or b) apovincaminic acid or vincaminic acid is esterified with a corresponding alcohol of the general formula R^-OH, wherein R1 represents an alkyl group containing 2 to 6 carbon atoms , an alkyl group substituted by a halogen atom or a hydroxy group containing 2 to 6 carbon atoms , an alkenyl group or a phenylalkyl group in the presence of one or more catalysts, preferably in the presence of mineral or organic acids or aliphatic or aromatic sulfonic acids, or c) apovincamine or vincamine is reacted with a corresponding alkali metal alcoholate, or d) apovincaminic or vincaminic acid, or, respectively, apovincamine or vincamine is reacted with a corresponding -24- 40457/2 and, if desired, the thus-obtained compounds of the general formula (ί) are converted into their acid addition salts or quaternary salts by reacting them with a mineral or organic acid or with an alk l halide, respectively, finally, if desired, the obtained salts are converted to the free basee, and the free bases are converted into other salts thereof, 12) A process as claimed in claim li1, Method a), in which the reaction is carried out in the presenoe of a solvent, preferably in the presence of ethanol and/or of an excess of the esterifying agent, at the boiling point of the mixture. 13) A process as claimed in claim 11, Method b , in which the reaction is carried out in the presence of a solvent, preferably in benzene, toluene and/or in the excess of the appropriate alcohol or in the mixture of said solvents, at the boiling point of the mixture. 14) A process as claimed in claim 11;, Method . c), in which the reaction is carried out- preferably in an apolar solvent or solvent mixture at the boiling point of the reaction mixture, and preferably sodium alcoholate is used as reagent. 15) !A procesB as claimed in claim 11, Method d), in which the reaction ie carried out in a solvent or solvent mixture^ preferably in an alcohol and/or in the excess of the ester reagent, at the boiling point of the reaction mixture* -25- 40457/2 16) A compound as claimed in any of claims 1 to 10, with special reference to the Examples. 17) A process as claimed in any of claims 11 to 15, with special reference to the Examples. 18) Pharmaceutical products containing at least one compound o the general formula (I) in claim 1 or a salt or quaternary derivative thereof, optionally together with other therapuetically active agent (s) and with a carrier or diluent. 19) A process for the preparation of pharmaceutical products, in which one or more compound(s) of the general formula (I) in claim 1, and/or the corresponding salts and/or the corresponding quaternary derivatives are converted alone, or together with other therapeutically active agent (s) , e.g. combined with reserpine, into pharmaceutical products, using carriers and auxiliary substances usable in the pharmaceutical industry.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HURI454A HU163434B (en) | 1971-11-03 | 1971-11-03 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL40457A0 IL40457A0 (en) | 1972-11-28 |
| IL40457A true IL40457A (en) | 1976-11-30 |
Family
ID=11000880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL40457A IL40457A (en) | 1971-11-03 | 1972-09-28 | Esters and salts of vincaminic and apovincaminic acid their preparation and pharmaceutical compositions containing them |
Country Status (28)
| Country | Link |
|---|---|
| JP (1) | JPS5132640B2 (en) |
| AT (1) | AT322118B (en) |
| AU (1) | AU469544B2 (en) |
| BE (1) | BE790837A (en) |
| BG (3) | BG25515A3 (en) |
| CA (1) | CA991187A (en) |
| CH (1) | CH580628A5 (en) |
| CS (1) | CS191208B2 (en) |
| DD (1) | DD101895A5 (en) |
| DE (3) | DE2265169C3 (en) |
| DK (1) | DK140552B (en) |
| EG (1) | EG10707A (en) |
| ES (1) | ES408180A1 (en) |
| FI (1) | FI56687C (en) |
| FR (1) | FR2158229B1 (en) |
| GB (1) | GB1405127A (en) |
| HU (1) | HU163434B (en) |
| IL (1) | IL40457A (en) |
| IN (1) | IN138719B (en) |
| KE (1) | KE2912A (en) |
| NL (1) | NL171584C (en) |
| NO (1) | NO136714C (en) |
| PL (2) | PL84613B1 (en) |
| RO (2) | RO62453A (en) |
| SE (1) | SE402460B (en) |
| SU (1) | SU578005A3 (en) |
| YU (1) | YU36738B (en) |
| ZA (1) | ZA726619B (en) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2259612B1 (en) * | 1974-01-31 | 1977-09-09 | Synthelabo | |
| HU171662B (en) * | 1975-07-18 | 1978-02-28 | Richter Gedeon Vegyeszet | Process for preparing new optically active derivatives of apovincaminol and acid addition salts thereof |
| US4122179A (en) * | 1976-06-03 | 1978-10-24 | Enrico Corvi Mora | Acid addition salts of vincamine and apovincamine |
| HU177370B (en) * | 1977-07-27 | 1981-09-28 | Richter Gedeon Vegyeszet | Process for producing new bracket-cross-bracket-vincaminol-esters |
| JPS55100383A (en) * | 1979-01-25 | 1980-07-31 | Sumitomo Chem Co Ltd | Preparation of novel nitrogen-containing polycyclic compound |
| AU532001B2 (en) * | 1978-11-20 | 1983-09-15 | Sumitomo Chemical Company, Limited | Polycyclic indole derivatives |
| CH645269A5 (en) * | 1979-08-16 | 1984-09-28 | Richter Gedeon Vegyeszet | Medicine for the skin, and process for its production |
| JPS56161388A (en) * | 1980-05-16 | 1981-12-11 | Nippon Zoki Pharmaceut Co Ltd | Novel vincamine derivative |
| IT1148733B (en) * | 1980-11-14 | 1986-12-03 | Medea Res Srl | VINCAMIN DERIVATIVES, METHOD FOR ITS PHARMACEUTICAL PREPARATION AND COMPOSITION THAT CONTAIN IT |
| HU192013B (en) * | 1984-04-25 | 1987-04-28 | Richter Gedeon Vegyeszet | Process for production of new aporincavinol esther derivatives |
| HU191938B (en) * | 1984-07-11 | 1987-04-28 | Andras Vedres | Process for production of new derivatives of 9 and 11 nitro-apovincamin acid |
| ES8604956A1 (en) * | 1985-11-20 | 1986-03-16 | Covex Sa | Process for the obtention of the ethyl ester of the apovincaminic acid |
-
0
- BE BE790837D patent/BE790837A/en not_active IP Right Cessation
-
1971
- 1971-11-03 HU HURI454A patent/HU163434B/hu unknown
-
1972
- 1972-09-25 AT AT821872A patent/AT322118B/en not_active IP Right Cessation
- 1972-09-27 ZA ZA726619A patent/ZA726619B/en unknown
- 1972-09-28 NO NO3470/72A patent/NO136714C/en unknown
- 1972-09-28 GB GB4489272A patent/GB1405127A/en not_active Expired
- 1972-09-28 IL IL40457A patent/IL40457A/en unknown
- 1972-09-28 AU AU47179/72A patent/AU469544B2/en not_active Expired
- 1972-10-02 DD DD165983A patent/DD101895A5/xx unknown
- 1972-10-17 FR FR7236735A patent/FR2158229B1/fr not_active Expired
- 1972-10-18 PL PL1972173980A patent/PL84613B1/en unknown
- 1972-10-18 PL PL1972158330A patent/PL83604B1/en unknown
- 1972-10-20 CH CH1537172A patent/CH580628A5/xx not_active IP Right Cessation
- 1972-10-20 RO RO7272589A patent/RO62453A/en unknown
- 1972-10-20 RO RO7200080703A patent/RO63055A/en unknown
- 1972-10-21 EG EG439/72A patent/EG10707A/en active
- 1972-10-23 FI FI2929/72A patent/FI56687C/en active
- 1972-10-27 IN IN1758/72A patent/IN138719B/en unknown
- 1972-10-27 SE SE7213934A patent/SE402460B/en unknown
- 1972-10-30 NL NLAANVRAGE7214672,A patent/NL171584C/en not_active IP Right Cessation
- 1972-10-30 JP JP47108028A patent/JPS5132640B2/ja not_active Expired
- 1972-11-01 BG BG023711A patent/BG25515A3/en unknown
- 1972-11-01 BG BG023710A patent/BG22830A3/en unknown
- 1972-11-01 DK DK540472AA patent/DK140552B/en not_active IP Right Cessation
- 1972-11-01 BG BG021764A patent/BG20602A3/en unknown
- 1972-11-02 DE DE2265169A patent/DE2265169C3/en not_active Expired
- 1972-11-02 DE DE2265138A patent/DE2265138C3/en not_active Expired
- 1972-11-02 ES ES408180A patent/ES408180A1/en not_active Expired
- 1972-11-02 DE DE2253750A patent/DE2253750C3/en not_active Expired
- 1972-11-02 CA CA155,420A patent/CA991187A/en not_active Expired
- 1972-11-02 SU SU7201845297A patent/SU578005A3/en active
- 1972-11-03 YU YU2735/72A patent/YU36738B/en unknown
- 1972-11-03 CS CS727419A patent/CS191208B2/en unknown
-
1979
- 1979-01-04 KE KE2912A patent/KE2912A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL40457A (en) | Esters and salts of vincaminic and apovincaminic acid their preparation and pharmaceutical compositions containing them | |
| US4152326A (en) | Cyclic sulphonyloxyimides | |
| IE792027L (en) | Pyrroloazetidinones | |
| IL57752A (en) | Preparation of 1-desoxy-nojirimicin and n-substituted derivatives thereof | |
| GB1476215A (en) | Dibenzoxepin derivatives process for the preparation thereof and pharmaceutical compositions containing them | |
| CS228912B2 (en) | Method of preparing isosorbid-5-nitrate | |
| GB2264944A (en) | 2-amino-2,4,4-trimethylpentane salt of clavulanic acid | |
| KR860007266A (en) | Method for preparing alkenamido cephalosporin ester | |
| ES485650A1 (en) | Process for the preparation of 1,2,3-thiadiazol-5-yl ureas | |
| ES8200681A1 (en) | Process for preparing derivatives of 5,11-dihydro-6h-pyrido[2,3-b][1,4]-benzodiazepin-6-one, and the final derivatives and synthesis intermediates obtained thereby | |
| GB984471A (en) | Anthranilic acid esters and methods for producing the same | |
| US5117015A (en) | Process for production of 1-α, 3-β, 24-trihydroxy Δ-5 | |
| SU1435153A3 (en) | Method of producing ethyl ester of apotartaric acid | |
| GB1476053A (en) | Glycyrrhetinic acid derivatives | |
| US3161634A (en) | Process of making nu-acyl derivatives of 6-amino-penicillanic acid | |
| EP0386538A3 (en) | Process for preparing high purity 3-alpha-7-beta-dihydroxycholanic acid | |
| IE43413L (en) | Behenic acid ester | |
| US2854454A (en) | Rescennamine | |
| SU419031A3 (en) | METHOD FOR PREPARING COMPLEX ETHERS 1,2,3,6-TETRAGIDRO-4-Pyridyl Methyl Carbo Novo and Acids with Their Salts or Quarterly Salts | |
| ES8605766A1 (en) | Benzoic acid derivatives | |
| GB2110208A (en) | Vincaminic acid esters | |
| US4900841A (en) | 1-[4-[(methyl-sulfonyl)amino]benzoyl]aziridine | |
| US2808410A (en) | Reserpone and process and intermediates for the preparation thereof | |
| GB1368896A (en) | Mycophenolic acid derivatives and process for production thereof | |
| IE41131B1 (en) | 3-(4-(2-alkoxy carbonylamino ethyl)-phenoxy)-1-isopropylamino-propan-2-ols, methods for their preparation and compositions containing them |